Literature DB >> 11900341

Heat stress and/or endotoxin effects on cytokine expression by human whole blood.

David A DuBose1, James Balcius, David Morehouse.   

Abstract

Immune system cytokines induce vascular shock. Tumor necrosis factor-alpha (TNF-alpha), interleukin 1beta (IL-1beta), and bacterial endotoxin (E) circulate in human heatstroke to suggest that E release from a heat-damaged gut may stimulate cytokines that contribute to hypovolemia. However, immune activation by heat-induced tissue necrosis might stimulate cytokine generation in the absence of E. To evaluate this potential and heat stress effects on the anti-inflammatory cytokines, IL-1 receptor antagonist (IL-1ra) and IL-1 soluble receptor II (IL-1srII), a human whole blood (HWB) model was employed in which the presence or absence of E could be controlled. Using thermoelectric technology to regulate the HWB heat exposures, the temperature modulations of lethal heatstroke were precisely replicated (maximum temperature = 42.4 degrees C +/- 0.04 degrees C; thermal area = 52.3 degrees C +/- 1.5 degrees C per min). Cytokine and mRNA measurements employed enzyme-linked immunosorbant-based assay systems. Significant elevations in TNF-alpha, IL-1beta, interleukin 6 (IL-6), and IL-1ra resulted when HWB was exposed to E concentrations (10 ng/ml) reported to circulate in heatstroke. While E-stimulated IL-1ra was significantly decreased by the presence of prior heat stress (PPHS), E-stimulated IL-1beta, TNF-alpha, and IL-6 were not significantly altered by PPHS, but tended to be elevated. IL-1srII expression was unchanged by PPHS and/or E. PPHS in the absence of E did not induce cytokine responses, nor were there elevations in TNF-alpha or IL-1beta mRNA. Thus, some factor normally absent under in vitro conditions, like endotoxin, was required to provoke HWB cytokine expressions and the heat stress and E conditions that characterize heatstroke affected HWB cytokine metabolism to favor a proinflammatory environment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900341     DOI: 10.1097/00024382-200203000-00010

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

Review 1.  Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance.

Authors:  Trupti D Vardam; Lei Zhou; Michelle M Appenheimer; Qing Chen; Wang-Chao Wang; Heinz Baumann; Sharon S Evans
Journal:  Cytokine       Date:  2007-07       Impact factor: 3.861

Review 2.  Can body temperature dysregulation explain the co-occurrence between overweight/obesity, sleep impairment, late-night eating, and a sedentary lifestyle?

Authors:  Rhonda F Brown; Einar B Thorsteinsson; Michael Smithson; C Laird Birmingham; Hessah Aljarallah; Christopher Nolan
Journal:  Eat Weight Disord       Date:  2017-09-19       Impact factor: 4.652

3.  Effect of environmental hyperthermia on gastrin, somatostatin and motilin in rat ulcerated antral mucosa.

Authors:  Feng-Peng Sun; Yu-Gang Song
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

4.  The Jak/STAT signaling pathway is downregulated at febrile temperatures.

Authors:  Tobias Nespital; Ger J Strous
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

5.  Differential Expression Pattern of Exosome Long Non-Coding RNAs (lncRNAs) and MicroRNAs (miRNAs) in Vascular Endothelial Cells Under Heat Stroke.

Authors:  Huai-Sheng Chen; Hua-Sheng Tong; Ying Zhao; Cheng-Ying Hong; Jian-Ping Bin; Lei Su
Journal:  Med Sci Monit       Date:  2018-11-06

6.  Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6.

Authors:  Arcangelo Liso; Stefano Castellani; Francesca Massenzio; Rosa Trotta; Alessandra Pucciarini; Barbara Bigerna; Pasquale De Luca; Pietro Zoppoli; Filippo Castiglione; Maria Concetta Palumbo; Fabrizio Stracci; Matteo Landriscina; Giorgina Specchia; Leon A Bach; Massimo Conese; Brunangelo Falini
Journal:  Oncotarget       Date:  2017-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.